XENE

Xenon Pharmaceuticals Inc.

39.68 USD
-0.12 (-0.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Xenon Pharmaceuticals Inc. stock is down -0.5% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 May’s closed higher than April. In the last 3 Unusual Options Trades, there were 3 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
06 May 14:11 17 Jan, 2025 42.50 CALL 60 0
06 May 14:17 17 Jan, 2025 42.50 CALL 60 0
06 May 14:18 17 Jan, 2025 42.50 CALL 60 0

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy. XEN007, a central nervous system-acting calcium channel modulator, is in Phase II clinical trials.

  • Needham
    Fri May 10, 18:01
    buy
    confirm
  • Citigroup
    Fri May 10, 17:37
    buy
    confirm
  • Wedbush
    Fri May 10, 09:19
    buy
    confirm